University spinout receives £ 1.2 million to tackle antimicrobial resistance

(University of Plymouth) Amprologix Limited, a University of Plymouth spinout company, has won a £ 1.2 million contract from the Department for Health and Social Care to accelerate development and scale up its lead antibiotic candidate to tackle antimicrobial resistant MRSA and related superbugs.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news